Cure My Disease

Don't miss your cure!

 Log in / Sign up

Digital therapy aims to help teens with chronic pain face their fears

NCT ID NCT05079984

Completed Symptom relief Sponsor: Stanford University Source: ClinicalTrials.gov ↗

First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time

Summary

This trial is testing a digital program called iGET Living for adolescents aged 10–18 with chronic musculoskeletal pain. The program uses graded exposure therapy, a behavioral approach that helps patients gradually face feared and avoided activities. The study will first test the program's acceptability in a small group, then evaluate its feasibility and preliminary effectiveness in a larger group using a single-case experimental design.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a digitally delivered graded exposure treatment called iGET Living
What this could lead to
If effective, this digital program could offer a scalable, accessible way to help teens with chronic pain get back to normal activities.
What could go wrong
This is an early-stage feasibility trial with a small sample and no control group, so results may not generalize or prove effectiveness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADOLESCENT BEHAVIOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Adolescent Behavior Child Behavior Chronic Pain chronic pain syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADOLESCENT BEHAVIOR CHILD BEHAVIOR CHRONIC PAIN EXPOSURE

Contacts and locations

Locations

  • Pediatric Pain Management Clinic

    Menlo Park, California, 94025, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.